Celltrion Group provides biosimilar and innovative biopharmaceutical medications to help increase patient access to advanced therapies around the world.
Celltrion Group offers biologics to about 110 countries, along with more than 30 global partners around the world. With hands-on experience and knowledge accumulated through years of working in the advanced pharmaceutical markets around the world, Celltrion Group has been securing distribution channels and providing patients with biosimilars at affordable prices.
Supporting the company in a context of change, transformation, and the implementation of new processes, etc.
Recruitment
Training
What We Do
Celltrion is a leading global biopharmaceutical company headquartered in Incheon, South Korea. It specializes in the research, development, manufacturing, marketing, and sales of biosimilars and innovative therapeutics. The company is dedicated to improving patient access to advanced medications through its fully integrated model, which encompasses the entire process from research and development to clinical trials, regulatory affairs, production, and global distribution.
